High-Mobility Group Box-1 Mediates Toll-Like Receptor 4–Dependent Angiogenesis

Abstract

Our results suggest that the release of HMGB1 in the wounds initiates TLR4-dependent responses that contribute to neovascularization. Thus, targeting HMGB1-TLR4 signaling cascade may constitute a novel therapeutic approach to angiogenesis-related diseases.